Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Matthew W. McCarthy. (2023) Montelukast as a potential treatment for COVID-19. Expert Opinion on Pharmacotherapy 24:5, pages 551-555.
Read now
Read now
Josuel Ora, Luigino Calzetta, Chiara Frugoni, Ermanno Puxeddu & Paola Rogliani. (2023) Expert guidance on the management and challenges of long-COVID syndrome: a systematic review. Expert Opinion on Pharmacotherapy 24:3, pages 315-330.
Read now
Read now
Ahsan R. Khan, Christian Misdary, Nikhil Yegya-Raman, Sinae Kim, Navaneeth Narayanan, Sheraz Siddiqui, Padmini Salgame, Jared Radbel, Frank De Groote, Carl Michel, Janice Mehnert, Caleb Hernandez, Thomas Braciale, Jyoti Malhotra, Michael A. Gentile & Salma K. Jabbour. (2022) Montelukast in hospitalized patients diagnosed with COVID-19. Journal of Asthma 59:4, pages 780-786.
Read now
Read now
Hamidreza Khodajou-Masouleh, S. Shirin Shahangian & Behnam Rasti. (2021) Reinforcing our defense or weakening the enemy? A comparative overview of defensive and offensive strategies developed to confront COVID-19. Drug Metabolism Reviews 53:4, pages 508-541.
Read now
Read now
Articles from other publishers (13)
Buket Basa Akdoğan & Selcan Gültuna. (2023) The relationship between aeroallergen sensitivity variations and Covid 19 in patients with rhinitis. Medical Science and Discovery 10:8, pages 601-611.
Crossref
Crossref
Sarah K. Wise, Cecelia Damask, Lauren T. Roland, Charles Ebert, Joshua M. Levy, Sandra Lin, Amber Luong, Kenneth Rodriguez, Ahmad R. Sedaghat, Elina Toskala, Jennifer Villwock, Baharudin Abdullah, Cezmi Akdis, Jeremiah A. Alt, Ignacio J. Ansotegui, Antoine Azar, Fuad Baroody, Michael S. Benninger, Jonathan Bernstein, Christopher Brook, Raewyn Campbell, Thomas Casale, Mohamad R. Chaaban, Fook Tim Chew, Jeffrey Chambliss, Antonella Cianferoni, Adnan Custovic, Elizabeth Mahoney Davis, John M. DelGaudio, Anne K. Ellis, Carrie Flanagan, Wytske J. Fokkens, Christine Franzese, Matthew Greenhawt, Amarbir Gill, Ashleigh Halderman, Jens M. Hohlfeld, Cristoforo Incorvaia, Stephanie A. Joe, Shyam Joshi, Merin Elizabeth Kuruvilla, Jean Kim, Adam M. Klein, Helene J. Krouse, Edward C. Kuan, David Lang, Desiree Larenas‐Linnemann, Adrienne M. Laury, Matt Lechner, Stella E. Lee, Victoria S. Lee, Patricia Loftus, Sonya Marcus, Haidy Marzouk, Jose Mattos, Edward McCoul, Erik Melen, James W. Mims, Joaquim Mullol, Jayakar V. Nayak, John Oppenheimer, Richard R. Orlandi, Katie Phillips, Michael Platt, Murugappan RamanathanJrJr, Mallory Raymond, Chae‐Seo Rhee, Sietze Reitsma, Matthew Ryan, Joaquin Sastre, Rodney J. Schlosser, Theodore A. Schuman, Marcus S. Shaker, Aziz Sheikh, Kristine A. Smith, Michael B. Soyka, Masayoshi Takashima, Monica Tang, Pongsakorn Tantilipikorn, Malcolm B. Taw, Jody Tversky, Matthew A. Tyler, Maria C. Veling, Dana Wallace, De Yun Wang, Andrew White & Luo Zhang. (2023) International consensus statement on allergy and rhinology: Allergic rhinitis – 2023. International Forum of Allergy & Rhinology 13:4, pages 293-859.
Crossref
Crossref
Marta Reina-Couto, Mariana Roboredo-Madeira, Patrícia Pereira-Terra, Carolina Silva-Pereira, Sandra Martins, Luísa Teixeira-Santos, Dora Pinho, Andreia Dias, Gonçalo Cordeiro, Cláudia Camila Dias, António Sarmento, Margarida Tavares, João T. Guimarães, Roberto Roncon-Albuquerque, José-Artur Paiva, António Albino-Teixeira & Teresa Sousa. (2023) Evaluation of urinary cysteinyl leukotrienes as biomarkers of severity and putative therapeutic targets in COVID-19 patients. Inflammation Research 72:3, pages 475-491.
Crossref
Crossref
Aliae A. R. Mohamed Hussein, Mohamed Eltaher A. A. Ibrahim, Hoda A. Makhlouf, Nahed A. Makhlouf, Howaida K. Abd-Elaal, Karima M. S. Kholief & Islam G. Sayed. (2022) Value of montelukast as a potential treatment of post-COVID-19 persistent cough: a non-randomized controlled pilot study. The Egyptian Journal of Bronchology 16:1.
Crossref
Crossref
Afolarin Otunla, Karen Rees, Paddy Dennison, Richard Hobbs, Jana Suklan, Ella Schofield, James Gunnell, Alexandra Mighiu & Jamie Hartmann-Boyce. (2022) Risks of infection, hospital and ICU admission, and death from COVID-19 in people with asthma: systematic review and meta-analyses. BMJ Evidence-Based Medicine 27:5, pages 263-273.
Crossref
Crossref
Milena Sokolowska, G Enrico Rovati, Zuzana Diamant, Eva Untersmayr, Jürgen Schwarze, Zuzanna Lukasik, Florentina Sava, Alba Angelina, Oscar Palomares, Cezmi A. Akdis, Liam O'Mahony, Milos Jesenak, Oliver Pfaar, María José Torres, Marek Sanak, Sven‐Erik Dahlén & Grzegorz Woszczek. (2022) Effects of non‐steroidal anti‐inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID‐19. Allergy 77:8, pages 2337-2354.
Crossref
Crossref
Marina Camera, Paola Canzano, Marta Brambilla & G. Enrico Rovati. (2022) Montelukast Inhibits Platelet Activation Induced by Plasma From COVID-19 Patients. Frontiers in Pharmacology 13.
Crossref
Crossref
Lorena Urda, Matthias Heinrich Kreuter, Jürgen Drewe, Georg Boonen, Veronika Butterweck & Thomas Klimkait. (2022) The Petasites hybridus CO2 Extract (Ze 339) Blocks SARS-CoV-2 Replication In Vitro. Viruses 14:1, pages 106.
Crossref
Crossref
E. S. Ovsyannikov, S. N. АvdeevA. V. Budnevskiy, E. S. Drobysheva & I. A. Savushkina. (2021) Bronchial Asthma and COVID-19: Comorbidity Issues. Tuberculosis and Lung Diseases 99:9, pages 6-14.
Crossref
Crossref
René Lima-Morales, Pablo Méndez-Hernández, Yvonne N. Flores, Patricia Osorno-Romero, Christian Ronal Sancho-Hernández, Elizabeth Cuecuecha-Rugerio, Adrián Nava-Zamora, Diego Rolando Hernández-Galdamez, Daniela Karola Romo-Dueñas & Jorge Salmerón. (2021) Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico. International Journal of Infectious Diseases 105, pages 598-605.
Crossref
Crossref
Mangaldeep Dey & Rakesh Kumar Singh. (2021) Possible Therapeutic Potential of Cysteinyl Leukotriene Receptor Antagonist Montelukast in Treatment of SARS-CoV-2-Induced COVID-19. Pharmacology 106:9-10, pages 469-476.
Crossref
Crossref
Ameneh Norouzi. (2020) Treatment of SARS-CoV-2 (COVID-19) cases by the oral administration of montelukast tablets. Bionatura 5:4, pages 1304-1308.
Crossref
Crossref
Jean Barré, Jean-Marc Sabatier & Cédric Annweiler. (2020) Montelukast Drug May Improve COVID-19 Prognosis: A Review of Evidence. Frontiers in Pharmacology 11.
Crossref
Crossref